Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Advances in genome testing are helping to improve the outcomes for people who are battling cancer.  There is cutting-edge technology offering more accurate diagnosis, and today’s technologies allow doctors to match treatments with each patient’s cancer.  Dr. Francisco Velazquez from PAML joins us to explain.

Knowing the risk of being an OTC carrier and how to prepare for it with the UCD Genetic Testing Program, sponsored by Horizon Therapeutics and performed by Invitae.

Acromegaly is a slow-progressing disorder that occurs when the pituitary gland produces too much growth hormone.

Up next, stay tuned for a brand-new Behind the Mystery special — only on The Balancing Act.